Aquinox Pharma appoints two executives
Ms. Jenkins has amassed nearly 20 years of commercial leadership experience spanning start-up Biotech enterprises to large Pharmaceutical companies. She specializes in launching brands into markets with high unmet clinical needs and brings expertise leading strategic marketing, sales, and market access functions.
Most recently Mrs. Jenkins served as Vice-President, Market Access at Relypsa. She previously served as Vice President, Business Development at Actavis, (now Allergan plc) as well as Senior Director of Marketing at MedImmune. She also brings eight years of senior marketing and sales experience with Pfizer Inc.
Mr. Brennan brings more than 25 years of experience in building and leading pharmaceutical and biotechnology companies in the United States, Europe and Canada with a strong track-record in partnering and licensing transactions.
Previously, Mr. Brennan was Senior Vice-President of Business Development at Arbutus Biopharma Corp. (formerly Tekmira Pharmaceuticals Corp.) prior to which he served as CEO of Altair Therapeutics.
He also served in senior business development and regulatory affairs roles with AstraZeneca PLC, operating in Sweden, the United Kingdom and Canada. ■
LATEST MOVES FROM British Columbia
- Arbutus Biopharma appoints Daniel Burgess as director
- International Lithium Corp. names CFO, announces further additions
- Asiamet Resources appoints Peter John Bird as CEO
- International Lithium Corp. names Maurice Brooks to board
- Conifex Timber adds Janine North to board
More inside POST
How to alienate yourself on the new job Leadership